“Interleukin-2 Receptor Antagonist Therapy Leads to Increased Tacrolimus Levels After Kidney Transplantation”, Ther Drug Monit, vol. 37, pp. 206-213, 2015.
, “New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial”, Am J Transplant, vol. 15, pp. 1982-1990, 2015.
, “Acute Rejection Characteristics From a Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Early Corticosteroid Withdrawal”, Transplantation, vol. 95, pp. 573-579, 2013.
, “Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter Study”, Am J Transplant, vol. 13, pp. 474-484, 2013.
, ,
“Correlation of Tacrolimus Through Blood Levels to Rejection and Adverse Events After Kidney Transplantation”, in American Transplant Congress, Seattle, Washington, 2005.
, “The Influence of Immunomodulatory Diets on Transplant Success and Complications”, Transplantation, vol. 79, pp. 460-465, 2005.
, “A Randomized, Prospective, Multicenter Comparison of Tacrolimus, Mycophenolate Mofetil (MMF) and Steroids vs Cyclosporine Microemulsion, MMF and Steroids vs Tacrolimus, Sirolimus and Steroids in De Novo Cardiac Transplant Recipients - 12 Month Report”, in International Society for Heart and Lung Transplantation, Philadelphia, PA, 2005.
, , , ,